Sanford Among First Sites to Offer EXTEND Trial for Type 1 Diabetes

Sanford Among First Sites to Offer EXTEND Trial for Type 1 Diabetes
SIOUX FALLS, S.D. (PRWEB) June 09, 2015 Sanford Health is among the first sites to offer the EXTEND trial, a clinical trial that will test the ability of the drug tocilizumab to slow disease progression and help maintain natural insulin production in individuals with newly diagnosed type 1 diabetes. Type 1 diabetes is the ...

Sanford Study Reveals Fetal Alcohol Spectrum Disorders Prevalence in U.S.

Sanford Study Reveals Fetal Alcohol Spectrum Disorders Prevalence in U.S.
SIOUX FALLS, S.D. (PRWEB) October 30, 2014 Nearly 5 percent of U.S. children may be affected by fetal alcohol spectrum disorders, according to a new study co-authored by Sanford Research’s Gene Hoyme, M.D., and Amy Elliott, Ph.D., and published by Pediatrics. The study, “Prevalence and characteristics of fetal alcohol spectrum disorders,” explored the incidence ...